Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Daily News

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

Shelley Wood

August 11, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

News Daily News

Good TAVI Outcomes in Young Patients, but Population Is Unique

Michael O'Riordan

October 22, 2021

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Daily News

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

Michael O'Riordan

January 31, 2020

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

L.A. McKeown

January 17, 2019

News Daily News

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Caitlin E. Cox

October 18, 2017

News Daily News

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Todd Neale

March 15, 2017

News Daily News

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

Todd Neale

September 29, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

News Daily News

Societies Recommend TAVR Program Requirements

L.A. McKeown

March 06, 2012

Advertisement

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Top Structural Heart News of 2022

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Good TAVI Outcomes in Young Patients, but Population Is Unique

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

Societies Recommend TAVR Program Requirements

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content